BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 27358565)

  • 1. Receptor-targeted, drug-loaded, functionalized graphene oxides for chemotherapy and photothermal therapy.
    Thapa RK; Choi JY; Poudel BK; Choi HG; Yong CS; Kim JO
    Int J Nanomedicine; 2016; 11():2799-813. PubMed ID: 27358565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers.
    Thapa RK; Choi Y; Jeong JH; Youn YS; Choi HG; Yong CS; Kim JO
    Pharm Res; 2016 Nov; 33(11):2815-27. PubMed ID: 27573575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier.
    Vinothini K; Rajendran NK; Ramu A; Elumalai N; Rajan M
    Biomed Pharmacother; 2019 Feb; 110():906-917. PubMed ID: 30572195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
    Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
    J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalized Graphene Oxide as a nanocarrier of new Copper (II) complexes for targeted therapy on nasopharyngeal carcinoma.
    Li G; Yang Y; Zhou R; Meng F; Li X
    Eur J Pharm Sci; 2018 Oct; 123():249-259. PubMed ID: 29981404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of chemo-photothermal for breast cancer therapy using folic acid (FA) modified zinc oxide nanosheet.
    Vimala K; Shanthi K; Sundarraj S; Kannan S
    J Colloid Interface Sci; 2017 Feb; 488():92-108. PubMed ID: 27821343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
    Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
    Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled quercetin release from high-capacity-loading hyperbranched polyglycerol-functionalized graphene oxide.
    Islami M; Zarrabi A; Tada S; Kawamoto M; Isoshima T; Ito Y
    Int J Nanomedicine; 2018; 13():6059-6071. PubMed ID: 30323593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate-modified Graphene Oxide as the Drug Delivery System to Load Temozolomide.
    Wang LH; Liu JY; Sui L; Zhao PH; Ma HD; Wei Z; Wang YL
    Curr Pharm Biotechnol; 2020; 21(11):1088-1098. PubMed ID: 32101121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
    Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
    Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.
    Guo F; Yu M; Wang J; Tan F; Li N
    ACS Appl Mater Interfaces; 2015 Sep; 7(37):20556-67. PubMed ID: 26322900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
    Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI
    Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilayer-Coated Liquid Crystalline Nanoparticles for Effective Sorafenib Delivery to Hepatocellular Carcinoma.
    Thapa RK; Choi JY; Poudel BK; Hiep TT; Pathak S; Gupta B; Choi HG; Yong CS; Kim JO
    ACS Appl Mater Interfaces; 2015 Sep; 7(36):20360-8. PubMed ID: 26315487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, in silico modelling and functionality theory of folate-receptor-targeted myricetin-loaded bovine serum albumin nanoparticle formulation for cancer treatment.
    Kunjiappan S; Govindaraj S; Parasuraman P; Sankaranarayanan M; Arunachalam S; Palanisamy P; Mohan UP; Babkiewicz E; Maszczyk P; Vellaisamy S; Panneerselvam T
    Nanotechnology; 2020 Apr; 31(15):155102. PubMed ID: 31775133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier.
    Nasrollahi F; Varshosaz J; Khodadadi AA; Lim S; Jahanian-Najafabadi A
    ACS Appl Mater Interfaces; 2016 Jun; 8(21):13282-93. PubMed ID: 27158834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid.
    Barahuie F; Saifullah B; Dorniani D; Fakurazi S; Karthivashan G; Hussein MZ; Elfghi FM
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():177-185. PubMed ID: 28254283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypericin-functionalized graphene oxide for enhanced mitochondria-targeting and synergistic anticancer effect.
    Han C; Zhang C; Ma T; Zhang C; Luo J; Xu X; Zhao H; Chen Y; Kong L
    Acta Biomater; 2018 Sep; 77():268-281. PubMed ID: 30006311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery.
    Malekmohammadi S; Hadadzadeh H; Farrokhpour H; Amirghofran Z
    Soft Matter; 2018 Mar; 14(12):2400-2410. PubMed ID: 29512668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH/Redox-Triggered Photothermal Treatment for Cancer Therapy Based on a Dual-Responsive Cationic Polymer Dot.
    Mazrad ZAI; Phuong PTM; Choi CA; In I; Lee KD; Park SY
    ChemMedChem; 2018 Nov; 13(22):2437-2447. PubMed ID: 30288948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.
    Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.